New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Blood test spots early pancreatic cancers with 97% accuracy

Blood test spots early pancreatic cancers with 97% accuracy

by Dennis ThompsonA blood test appears capable of detecting early-stage pancreatic cancers with up to 97% accuracy, a new study reports.The test looks for eight small RNA particles and eight larger DN
Oncology April 28,2024
Blood test spots early pancreatic cancers with 97% accuracy

Blood test spots early pancreatic cancers with 97% accuracy

by Dennis ThompsonA blood test appears capable of detecting early-stage pancreatic cancers with up to 97% accuracy, a new study reports.The test looks for eight small RNA particles and eight larger DN
Oncology April 28,2024
Exploring the role of RNA modification in normal hematopoiesis and acute myeloid leukemia pathogenesis

Exploring the role of RNA modification in normal hematopoiesis and acute myeloid leukemia pathogenesis

by Cactus CommunicationsThe review sheds light on the role of post-transcriptional RNA modifications in normal hematopoietic development and acute myeloid leukemia, and highlights novel therapeutic ta
Oncology April 28,2024
Exploring the role of RNA modification in normal hematopoiesis and acute myeloid leukemia pathogenesis

Exploring the role of RNA modification in normal hematopoiesis and acute myeloid leukemia pathogenesis

by Cactus CommunicationsThe review sheds light on the role of post-transcriptional RNA modifications in normal hematopoietic development and acute myeloid leukemia, and highlights novel therapeutic ta
Oncology April 28,2024
Video educates and connects men to prostate cancer screening options

Video educates and connects men to prostate cancer screening options

byPerelman School of Medicine at the University of PennsylvaniaCredit: Unsplash/CC0 Public DomainAs part of a comprehensive effort to improve cancer screenings among diverse communities, Penn Me
Oncology April 28,2024
Video educates and connects men to prostate cancer screening options

Video educates and connects men to prostate cancer screening options

byPerelman School of Medicine at the University of PennsylvaniaCredit: Unsplash/CC0 Public DomainAs part of a comprehensive effort to improve cancer screenings among diverse communities, Penn Me
Oncology April 28,2024
With cancer cases rising in young people, could earlier screenings help save lives?

With cancer cases rising in young people, could earlier screenings help save lives?

by Erin Kayata,Northeastern UniversityCredit: Pixabay/CC0 Public DomainCancer cases are increasing among young people, with rising instances of colorectal cancer in people under age 55 and cervi
Oncology April 28,2024
With cancer cases rising in young people, could earlier screenings help save lives?

With cancer cases rising in young people, could earlier screenings help save lives?

by Erin Kayata,Northeastern UniversityCredit: Pixabay/CC0 Public DomainCancer cases are increasing among young people, with rising instances of colorectal cancer in people under age 55 and cervi
Oncology April 28,2024
An exosome-based liquid biopsy shows promise for early detection of pancreatic cancer

An exosome-based liquid biopsy shows promise for early detection of pancreatic cancer

byAmerican Association for Cancer ResearchPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteAn investigational exosome-based liquid
Oncology April 28,2024
An exosome-based liquid biopsy shows promise for early detection of pancreatic cancer

An exosome-based liquid biopsy shows promise for early detection of pancreatic cancer

byAmerican Association for Cancer ResearchPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteAn investigational exosome-based liquid
Oncology April 28,2024
Oncologist suggests three ways to prevent head and neck cancer

Oncologist suggests three ways to prevent head and neck cancer

by Deb Balzer, Mayo Clinic News NetworkCredit: Jill Burrow from PexelsThroat cancer is one of the fastest-growing cancers, and it is often linked to HPV. Oropharyngeal cancer, or throat cancer, is a t
Oncology April 28,2024
Oncologist suggests three ways to prevent head and neck cancer

Oncologist suggests three ways to prevent head and neck cancer

by Deb Balzer, Mayo Clinic News NetworkCredit: Jill Burrow from PexelsThroat cancer is one of the fastest-growing cancers, and it is often linked to HPV. Oropharyngeal cancer, or throat cancer, is a t
Oncology April 28,2024
FDA approves Abecma for relapsed, refractory multiple myeloma

FDA approves Abecma for relapsed, refractory multiple myeloma

by Lori SolomonThe U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.
Oncology April 28,2024
FDA approves Abecma for relapsed, refractory multiple myeloma

FDA approves Abecma for relapsed, refractory multiple myeloma

by Lori SolomonThe U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.
Oncology April 28,2024
Investigational personalized vaccine provides clinical benefit for some patients with resected head and neck cancers

Investigational personalized vaccine provides clinical benefit for some patients with resected head and neck cancers

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainTG4050, a personalized neoantigen vaccine, induced tumor-specific immune responses and led to low rates of disease rela
Oncology April 28,2024
Investigational personalized vaccine provides clinical benefit for some patients with resected head and neck cancers

Investigational personalized vaccine provides clinical benefit for some patients with resected head and neck cancers

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainTG4050, a personalized neoantigen vaccine, induced tumor-specific immune responses and led to low rates of disease rela
Oncology April 28,2024
ACE inhibitor not protective against heart damage from chemotherapy

ACE inhibitor not protective against heart damage from chemotherapy

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainPatients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment with high-dose anthracyclin
Oncology April 28,2024
ACE inhibitor not protective against heart damage from chemotherapy

ACE inhibitor not protective against heart damage from chemotherapy

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainPatients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment with high-dose anthracyclin
Oncology April 28,2024
Metformin may help the immune system better identify breast cancer cells

Metformin may help the immune system better identify breast cancer cells

byUniversity of HelsinkiCredit: Unsplash/CC0 Public DomainMetformin is a widely prescribed drug for managing type 2 diabetes. In recent years, indications of its potential anticancer properties
Oncology April 28,2024
Metformin may help the immune system better identify breast cancer cells

Metformin may help the immune system better identify breast cancer cells

byUniversity of HelsinkiCredit: Unsplash/CC0 Public DomainMetformin is a widely prescribed drug for managing type 2 diabetes. In recent years, indications of its potential anticancer properties
Oncology April 28,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com